Senior Director, Technical Research

Ronald A. Rader is Senior Director, Technical Research, 25+ years’ experience as a biotechnology, pharmaceutical and chemical information specialist and publisher. Editor/Publisher of the Antiviral Agents Bulletin periodical, the Federal Bio-Technology Transfer Directory, Biopharmaceutical Products in the U.S. Market. Mr. Rader has been Manager of Information Services, Porton International plc, Gillette Medical Evaluation Labs., MITRE Corp.; Technical Resources Inc.; and Bio-Conversion Labs. info@bioplanassociates.com, +1 301-921-5979, www.bioplanassociates.com.

Ronald A. Rader

Economics of Perfusion Culture Media and Upstream Processing
Friday, February 19, 2021
Cell culture media and its development have been one of the most vital parameters influencing the performance and facilitating adoption of perfusion bioprocesses. read more
Accelerating Trends in Bioprocessing COVID-19 Crisis Intensifies Need for Collaborative Solutions
Tuesday, October 13, 2020
The trends affecting the biopharma industry that we’ve evaluated over the past decade have remained relatively stable. In this highly regulated healthcare industry segment, decision-makers often consider adoption of novel ... read more
Biosimilars Set to Further Expand the Biopharmaceutical Market
Friday, March 22, 2019
Biosimilars are continuing to change the biopharmaceutical industry. Some biosimilars and biogeneric products have already entered world markets, and the rather full development pipeline1 means many more are coming, along ... read more
Biopharmaceutical Manufacturing is Shifting to Single-Use Systems. Are the Dinosaurs, the Large Stainless Steel ...
Tuesday, October 23, 2018
Single-use or disposable bioprocessing equipment is now used for =85% of pre-commercial scale, i.e., preclinical and clinical, biopharmaceutical manufacturing, and is increasingly being adopted for commercial products ... read more